Health ❯ Healthcare

Metabolic Disorders

Insulin Resistance Obesity Diabetes Phenylketonuria Hormonal Regulation Liver Health NASH Drug Development Weight Management Duchenne Muscular Dystrophy Fatty Liver Disease Cardiometabolic Care Endocrine Disorders Metabolic Dysfunction Diabetes Treatment Hormonal Therapies

Lancet Consensus Renames PCOS as Polyendocrine Metabolic Ovarian Syndrome

Experts say the new name reframes the condition as a systemic endocrine‑metabolic disease, shifting clinical focus toward early metabolic screening.

MouseMapper Maps Obesity’s Whole-Body Cellular Damage

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

Maze Therapeutics Reports Strong Phase 1 Signal for MZE782, Announces $150 Million Private Placement

Insulin Resistance Blood Test Forecasts Rapid Alzheimer’s Decline